VanEck Pharmaceutical ETF (PPH)

75.88
Delayed Data
As of 3:59pm ET
 +0.40 / +0.53%
Today’s Change
71.04
Today|||52-Week Range
84.27
-1.40%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS ® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Performance

1 month-1.82% 3 years+12.07%
3 months-1.58% 5 years+8.28%
1 year+1.78% Since inception+9.44%
Data through 08/06/2022

Quote Details

Previous close$75.48
Open day’s range75.53 – 76.25
Net asset value (NAV)75.50 (08/05/2022)
Daily volume7,983
Average volume (3 months)181,866
Data as of 3:59pm ET, 08/08/2022

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return+8.28%+7.33%
Expense Gross exp ratio0.35%1.01%
Risk 5 year sharpe ratio0.480.48
Net assets$571.9M$2.0B
Average market cap$72.4B$43.6B
Average P/E19.622.0
Dividend / Share--0.27%

Competitors

VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
IEHS iShares Evolved U.S. Healthcare Staples ...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
LLY Eli Lilly and Co5.37%
AZN AstraZeneca5.23%
NVO Novo Nordisk5.11%
MRK Merck5.10%
JNJ Johnson & Johnson5.03%
NVS Novartis5.02%
MCK Mckesson Corp4.98%
TAK Takeda Pharmaceutical4.95%
BMY Bristol-Myers Squibb4.95%
ABBV AbbVie4.91%